BZD9L1 sirtuin inhibitor as a potential adjuvant for sensitization of colorectal cancer cells to 5-fluorouracil
Background: This study aims to investigate the combination effect of a novel sirtuin inhibitor (BZD9L1) with 5-fluorouracil (5-FU) and to determine its molecular mechanism of action in colorectal cancer (CRC). Methods: BZD9L1 and 5-FU either as single treatment or in combination were tested against...
Main Authors: | Yi Jer Tan, Yeuan Ting Lee, Sven H. Petersen, Gurjeet Kaur, Koji Kono, Soo Choon Tan, Amin M. S. Abdul Majid, Chern Ein Oon |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-09-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/1758835919878977 |
Similar Items
-
Cancer-Associated Fibroblasts: Epigenetic Regulation and Therapeutic Intervention in Breast Cancer
by: Yeuan Ting Lee, et al.
Published: (2020-10-01) -
Engineering a bzd cassette for the anaerobic bioconversion of aromatic compounds
by: María Teresa Zamarro, et al.
Published: (2017-11-01) -
Ontogeny and regional distribution of the GABAa/BZD receptor in the avian brain
by: LI,YU-JIANG, et al.
Published: (1991) -
Key Molecular Events in Cervical Cancer Development
by: Shandra Devi Balasubramaniam, et al.
Published: (2019-07-01) -
Minichromosome Maintenance Complex (MCM) Genes Profiling and MCM2 Protein Expression in Cervical Cancer Development
by: Kaur, Gurjeet, et al.
Published: (2019)